NEW YORK (GenomeWeb News) - Daiichi Pure Chemicals, Toshiba, and Toshiba Hokuto Electronics plan to co-develop microarray-based in vitro diagnostic systems and chips, the companies said today.
Under the agreement, the companies will first develop an IVD for human papilloma virus.
Daiichi Pure Chemicals and Toshiba have collaborated on the system since January 2004.
Toshiba Hokuto Electronics has supported development and prototype production and will take responsibility for manufacturing the commercialized chip and detection system.